“Declare the past, diagnose the present, foretell the future.”
– Hippocrates
Atopic dermatitis is a chronic disease with a genetic predisposition characterized by a rash, intense skin itching and suppressed immune functions of the skin.
It usually begins in childhood and people who have atopic dermatitis have hypersensitive skin, as well as a reduced threshold of irritation. As a result, atopic dermatitis is often associated with asthma, allergies, and chronic dermatitis.
Epidemiology, Etiology and Diagnosis
Atopic dermatitis occurs in 3-15% of the total population:
- Children 5-20%
- Adults 2-10%
The exact cause of the eczema is not completely clear: genetic predisposition – the phyllagrin gene, skin barrier disorder, “Hygiene hypothesis” or intestinal dysbiosis, which occurs in 80-90% of children with atopic dermatitis.
Diagnosis is based on blood tests and skin allergy testing for inhaled or nutritional antigens.
Treatment
Mostly symptomatic:
- topical steroids or calcineurin inhibitors (Elidel)
- antihistamines
- antibiotics for suspected skin bacterial infection
- and/or oral corticosteroids – eczema returns after discontinuation
They are effective but can also cause serious side effects if taken over a long period of time.
Salapon® provides a new therapeutic option.
The use of Salapon® together with standard therapy of atopic dermatitis improves the effectiveness of therapy in the form of:
Clinical improvement in 56.76% of patients
- Average SCORAD index decrease by 71.94%
Itching disappears during the day and night in 50% of patients
Itching disappears during the day and night in 50% of patients
Salapon® tablets lead to a visible improvement in the quality of the skin and the general condition of the body if they are used for 21 days in the treatment of detoxification of the body.